FREEDOMM: Fifth-Line or Later Real-World Evaluation of Efficacy and Disease Outcomes in Multiple Myeloma with Ciltacabtagene Autoleucel: Treatment-Free Interval and Overall Survival in the USA.

Adv Ther · 2026 · PMC13156228 · PMID 41874852

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among patients who received BT with PI, there was a directional improvement in TFI (adjusted HR 0.36, 95% CI 0.10–1.27) and OS (adjusted HR 0.30, 95% CI 0.08–1.11) compared to patients without BT, although estimates did not reach statistical significance due to low sample size and event rates.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.